|
| Upcoming Events weeks of Sept. 16 - Sept. 22 |
|
|
Sept. 16
|
The Pink Party
5 p.m., Bartini Prime in Suncrest Town Centre
WVCTSI hosting NIH speaker, 4 p.m., 1909 HSC
Kay Lund, Ph.D., director of the Division of Biomedical Research Workforce and extramural training officer will present “Navigating NIH Systems to Advance Your Career & Tips for Successful Grant Writing.” Please RSVP to sarah.haymond@hsc.wvu.edu. |
Sept. 18
|
Cancer Cell Biology Presents David E. Blask, MD/PhD
"Role of Nighttime and Daytime Light Exposure on the Circadian Regulation of Cancer Metabolic Signaling, Progression and Therapeutic Responsiveness" 12:00 p.m., HSN Room 3067
School of Public Health Diversity Week Keynote: Dr. Gilbert Singletary, "All Men Are Created Equal"
The School of Public Health will welcome international speaker and bestselling author, Gilbert “Gil” Singletary, PhD, JD, to campus as part of 2019 Diversity Week. WVU students, faculty and staff are encouraged to attend. |
Sept. 20
|
Cancer Institute Science Exchange presents Elena Pugacheva, PhD and Mike Ruppert MD/PhD
Developing Investigator-Initiated Clinical Trials in Breast Cancer
12:00-1:00 PM
Room G119A HSC North |
|
|
|
WVU Volleyball announces Pink Match date
WVU Volleyball's annual Pink Match will take place on Saturday, Nov. 16, at 1 p.m., vs. Texas Tech. The team will don pink jerseys in support of breast cancer awareness. WVU Medicine will sponsor the match and will collect donations for the WVU Cancer Institute. Fans are encouraged to wear pink and can get the WVU sports official "pink" t-shirt with a donation of $10 or more to WVU Medicine.
WVU Medicine announces Project SEARCH partnership
WVU Medicine announced today (Sept. 10) a partnership with Project SEARCH to provide internship experience for students with special needs. While the program itself has existed since 1996, WVU Medicine J.W. Ruby Memorial Hospital will be the state’s first location to host the internship experience.
Petros named to panel to review NCI applications for novel cancer treatments
Dr. William Petros, Pharm.D., Gates Wigner Dean of the WVU School of Pharmacy, has been selected to serve on the NCI Special Emphasis Panel for the Experimental Therapeutics Clinical Trails Network (UM1/U24).
This panel reviews applications from institutions proposing to participate in early phase development of novel cancer treatments.
WVU Medicine's Gamma Knife program provides high-quality treatment for inoperable tumors
For some cancer patients, having inoperable or at least risky-to-treat tumors doesn’t necessarily mean they’re untreatable if the right technology is applied. And that technology can be found at WVU Medicine.
Gamma Knife is a form of radiation treatment that narrows in on specific areas of the brain to deliver a highly concentrated dose to the targeted tumor without causing significant damage to the surrounding unaffected tissue.
“Most people that don’t carry cancer diagnoses are scared of the notion of radiation, but for the majority of patients who have been presented with cancer they become very tuned in to the importance of radiation in their treatment,” explained Dr. Christopher Cifarelli, director of the WVU Medicine Gamma Knife program.
NIH application seminar scheduled for September 24
WVCTSI and the WVU Office of Research and Graduate Education are hosting a special seminar on NIH applications. Courtney DeVries, Ph.D., the John T. and June R. Chambers Chair of Oncology Research at WVU, will present, "Addressing Rigor, Reproducibility, and Biological Variables in NIH Applications."
This event will take place Tuesday, September 24 from 12 to 1 p.m. in room 301 of the WVU Erma Byrd Biomedical Research Building.
Fall Cancer Conference registration and agenda now available
Plan to join the WVU Cancer Institute, WVU School of Medicine, WVU Medicine and the WVU Office of Continuing Education for the 29th Annual Fall Cancer Conference at the Erickson Alumni Center in Morgantown, WV on October 18th, 2019. View the Brochure | Register Now |
|
|
|
|
|
|
|
|
|
Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: Phase 3 CALGB 80802 randomized clinical trial.
Abou-Alfa GK, Shi Q, Knox JJ, Kaubisch A, Niedzwiecki D, Posey J, Tan BR, Jr., Kavan P, Goel R, Lammers PE, Bekaii-Saab TS, Tam VC, Rajdev L, Kelley RK, El Dika I, Zemla T, Potaracke RI, Balletti J, El-Khoueiry AB, Harding JH, Suga JM, Schwartz LH, Goldberg RM, Bertagnolli MM, Meyerhardt J, O'Reilly EM, Venook AP.
JAMA Oncol. 2019.
Modeling Human Cancer-induced Cachexia.
Talbert EE, Cuitino MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, Reiser PJ, Webb A, Timmers CD, Eiferman DS, Evans DC, Dillhoff ME, Schmidt CR, Guttridge DC.
Cell Rep. 2019;28(6):1612-1622 e1614. |
|
|
|
|
NIH Notices
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
(PAR-19-372)
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)
(PAR-19-377)
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)
(RFA-CA-19-042)
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
(RFA-CA-19-064)
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)
(RFA-HL-20-006)
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
(RFA-OD-19-027)
NIH Funding Opportunities
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
(PAR-19-367)
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
(PAR-19-369)
NIH Requests for Proposal
None this week
Other Funding or Opportunities
eRA Alert: Reminder to Thoroughly Check Grant Application Images in eRA Commons
We have received several reports of blank pages appearing in the assembled application images generated by the eRA system. In each case, the blank pages were shown in place of submitted PDF attachments generated from images (e.g., scanned documents) rather than text (e.g., Word files). The eRA team is working to isolate and address the root cause for the blank pages.
Grant applicants are reminded of their responsibility to check their application images in eRA Commons during the 2-business day application viewing window. Be sure to check the entire application, paying special attention to any scanned attachments. If you encounter any blank pages in place of application content, contact the eRA Service Desk immediately following our standard guidelines for Dealing with System Issues.
Applicants are also encouraged to take advantage of the Preview Application action in ASSIST, the Grantor Image tab in Workspace, or similar application preview functions available in other (S2S) systems to identify any potential assembly issues prior to submission.
Women in biomedical research brunch
The Females Advancing Clinical and Translational Science (FACTS) Group and the WVU Office of Research and Graduate Education are co-hosting a networking brunch for women in biomedical science on September 24. This brunch will give attendees a chance to network with colleagues and learn about upcoming research and professional development events.
This event will take place Tuesday, September 24 from 9 to 10:30 a.m. in room 201 of the WVU Erma Byrd Biomedical Research Building. Please RSVP to sarah.haymond@hsc.wvu.edu.
Bridge Funding Awards: Marsha Rivkin Center for Ovarian Cancer Research
Upcoming Deadline: Application: Oct. 15, 2019
The purpose of Bridge Funding is to allow researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding to researchers who have submitted to the NIH or DOD pertaining to ovarian cancer and who were not funded but received a score close to the funding threshold.
Grants Program for Myelodysplastic Syndromes (MDS) Research: Henry and Marilyn Taub Foundation
Upcoming Deadline: Application: Oct. 15, 2019
The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative translational research to understand the underlying causes of MDS and to advance its treatment and prevention. The Program specifically focuses on MDS research, exclusive of AML and MPN.
Communication and Dissemination Research: Patient-Centered Outcomes Research Institute (PCORI)
Upcoming Deadline: Letter of Intent:: Oct 1, 2019. Application (Invitation only): Jan. 14, 2020
The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our priority areas for research. This PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research, and Improving Health Systems.
Nancy Sanders Memorial Student and Faculty Travel and Research Abroad Grants Open for Submissions
In honor of the legacy of long-time staff member in WVU’s Global Health Program, the Global Engagement Office (GEO) at Health Sciences is pleased to announce that the application period for the Nancy Sanders Memorial Student Travel Grant and the Nancy Sanders Memorial Faculty Research Abroad Grant is now open.
AACR Anna D. Barker Fellowship in Basic Cancer Research: American Association for Cancer Research (AACR)
Upcoming Deadline: LOI: Sept. 24, 2019 Application (Invitation only): January 28, 2019
This fellowship provides funding to support the Fellow while working on a mentored basic cancer research project. The research proposed for funding may be in any area of basic cancer research.
|
|
|
|
Sept. 24
|
Current Topics in Mentorship Seminar Series
"Addressing Rigor, Reproducibility, and Biological Variables in NIH Applications"
12:00 PM, 301 BMRC
If you plan to attend, please RSVP
Evening of Science Focus on Dentistry- 4:00 PM, 2940A HSC North, Focus on Dentistry
If you plan to attend, please RSVP |
Oct. 18
|
Fall Cancer Conference - Erickson Alumni Center
View the Brochure | Register Now
Research Induction Ceremony - 4:00 PM, Okey Patteson Auditorium
Annual white coat ceremony celebrating all HSC doctoral students as they move into their graduate research careers. |
Oct. 20
|
WVU Women's Soccer - Dick Dlesk Soccer Stadium
WVU's Pink Match for breast cancer awareness, and all fans are encouraged to wear pink, as the team will celebrate its annual fundraising efforts for the Mary Babb Randolph Cancer Center.
|
Nov. 16
|
WVU Volleyball annual Pink Match - 1 p.m., vs. Texas Tech
The team will don pink jerseys in support of breast cancer awareness. WVU Medicine will sponsor the match and will collect donations for the WVU Cancer Institute.
|
Nov. 22
|
Annual Scientific Meeting and Hardesty Lecture
Erickson Alumni Center - 10:30 a.m. - 5 p.m.
|
See more on the WVU Cancer Institute Calendar |
|
|
|
|
|
|
|
